Why people use Semaglutide for Type 2 diabetes
Ozempic for diabetes. What's the typical A1C drop? The honest answer: yes, and it clears the highest bar - it is FDA-approved for this. SUSTAIN trials showed A1C reductions of 1.5-1.8 percentage points.
This page covers what's known, what's not, and what the editorial take is for normal humans considering Semaglutide for Type 2 diabetes.
What the evidence says
Evidence tier: FDA-approved. FDA-approved with multiple randomized trials behind it. The strongest evidence tier in this matrix.
- SUSTAIN trials showed A1C reductions of 1.5-1.8 percentage points.
- FDA-approved as Ozempic for adult Type 2 diabetes.
- Often first-line after metformin in newer treatment guidelines.
Protocol notes
Standard Ozempic titration: 0.25mg -> 0.5mg -> 1mg -> 2mg max.
Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.
What to skip
- Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
- Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
- Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.
Where to go next
- Full Semaglutide directory entry - status, sourcing, studies, what to skip
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- The Tier List - which ones to take seriously
- Subscribe to the dispatch